Associations of per- and polyfluoroalkyl substances (PFAS) with key metabolic cardiovascular disease risk factors. The tromsø study

This publication has 40 references indexed in Scilit:

• The relationship between PFAS exposure and dyslipidemia: an updated review, meta-analysis, and evaluation of bias
  European Journal of Epidemiology, 2025
• PFAS exposure is associated with an unfavourable metabolic profile in infants six months of age
  Environment International, 2024
• Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease – Results from two independent population-based cohorts and a meta-analysis
  Environment International, 2023
• Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease
  Environment International, 2023
• Association between perfluoroalkyl acids and the prevalence of hypertension among US adults
  Ecotoxicology and Environmental Safety, 2020
• Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population
  Environment International, 2018
• Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity
  JAMA Network Open, 2018
• Influence of exposure to perfluoroalkyl substances (PFASs) on the Korean general population: 10-year trend and health effects
  Environment International, 2018
• An automated high-throughput SPE micro-elution method for perfluoroalkyl substances in human serum
  Analytical and Bioanalytical Chemistry, 2015
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001